Navigation Links
Good bacteria to rescue of colitis patients

Colitis patients who don't respond well to conventional// therapy may soon get help from a bacteria mixture, reports science portal www.eurekalert.org.

Richard Fedorak, a professor of gastroenterology at the University of Alberta, and researchers from the University of Bologna in Italy and the University of North Carolina administered probiotic bacteria mixture VSL#3 over a six-week period to 30 patients aged 18-65.

Probiotics are preparations of living microbial cells that, when ingested, are thought to positively influence the composition of microbes in the gut and improve the health of the intestine.

Remission of colitis was achieved in 63 percent of patients, while another 23 percent responded with improvement in their symptoms and with healing of the colon's lining. There were no adverse effects to the medication, the study said.

In this open label clinical trial, 86 percent of those treated with probiotic bacteria mixture VSL#3 experienced relief of their mild to moderate ulcerative colitis.

The researchers found that the majority of patients taking VSL#3 for six weeks improved their ulcerative colitis. While "bad" bacteria have been flagged as potential culprits in the cause of inflammatory diseases of the bowel, in this case, the ingestion of supplemental "good" bacteria (probiotics) to the intestine proved beneficial in treating ulcerative colitis, Fedorak said.

The VSL#3 can be considered an important potential treatment for those patients who don't respond to conventional therapy such as mesalamine or 5ASA, he said.

(IANS)
'"/>




Page: 1

Related medicine news :

1. Kidney Stones - Interesting New Research implicates bacteria as its cause
2. Just spice it up!!!!! Anti bacterial effects of spices unraveled in the West
3. Dangerous food bacteria
4. Tongue piercing leads to bacterial infection
5. Honey curbs bacteria in the oral cavity
6. Identifying bacteria made amiable
7. The Effectiveness Of Antibacterial Products In Reducing Infection
8. Light can help fight gum bacteria
9. Asthma may increase the risk for bacterial infection of the lungs
10. Cystic fibrosis patients may require a new treatment for bacterial infection
11. Risks of heart attack related to bacteria in gum plaque
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2017)... TX (PRWEB) , ... February 27, 2017 , ... ... 75,000 customer threshold mark last week. In addition, Discount Power's RCE (Residential Customer ... Energy LLC in March 2014. The company had 800 customers and 2,250 RCEs ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair ... announce a new informational post on robotic hair transplantation. San Francisco residents may ... transplant and Follicular Unit Transplantation (FUT) can sound similar. Either treatment can be ...
(Date:2/27/2017)... ... ... New Jersey ranks among the top five states in the entire nation ... advanced services is growing. , Project WE vs C is a focused two-year ... non-profit partners in their fight against cancer and in support of their shared mission ...
(Date:2/26/2017)... Como, Italy (PRWEB) , ... February 26, 2017 ... ... its last call for entries to the 7th Edition of International Social Design ... by Social Design Professionals, Product Designers, System Designers, Governments and Institutions worldwide with ...
(Date:2/26/2017)... ... February 26, 2017 , ... NuevaCare, a leading home care agency based in ... Palo Alto, is proud to announce an important upgrade to its geographic information pages, ... care close to home, and by having city-specific pages, NuevaCare is answering that information ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Australie, le 24 février 2017 ITL Limited, ... santé diversifiée innovante, est ravie d,annoncer les excellents résultats ... la période précédente correspondante. Une présentation complète « Résultats et ... être consultée ici . Faits ... de 2,12 millions $ (Déc. 2015 : 1,04 million $ ; en hausse de ...
(Date:2/24/2017)... , Feb. 23, 2017 ... insights on the various drugs being developed ... covers all the drugs that are in ... Clinical). The pipeline focuses on novel pharmacologic ... antibodies, stem cell therapies, recombinant proteins and ...
(Date:2/24/2017)... Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology ... it has acquired exclusive worldwide rights to develop, ... HDAC inhibitor targeting hematological and solid tumors. ... 1 and 2 clinical trials of Abexinostat in ... have already been completed, demonstrating that Abexinostat is ...
Breaking Medicine Technology: